APA (7th ed.) Citation

Landry, I., Aluri, J., Hall, N., Filippov, G., Dayal, S., Moline, M., & Reyderman, L. (2021). Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant. Pharmacology research & perspectives, 9(2), e00734-n/a. https://doi.org/10.1002/prp2.734

Chicago Style (17th ed.) Citation

Landry, Ishani, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Satish Dayal, Margaret Moline, and Larisa Reyderman. "Effect of Severe Renal Impairment on Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacology Research & Perspectives 9, no. 2 (2021): e00734-n/a. https://doi.org/10.1002/prp2.734.

MLA (9th ed.) Citation

Landry, Ishani, et al. "Effect of Severe Renal Impairment on Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacology Research & Perspectives, vol. 9, no. 2, 2021, pp. e00734-n/a, https://doi.org/10.1002/prp2.734.

Warning: These citations may not always be 100% accurate.